Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

BATS BZX Real-Time Price
As of 11:54am ET
 -0.46 / -0.78%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month-13.30% 3 years+13.26%
3 months-0.29% 5 years+22.25%
1 year-9.70% Since inception+13.03%
Data through 10/25/2016

Quote Details

Previous close$59.15
Open day’s range58.64 – 59.56
Net asset value (NAV)59.09 (10/24/2016)
Daily volume263,987
Average volume (3 months)6,565,325
Data as of 11:54am ET, 10/25/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return+22.25%+20.22%
Expense Gross exp ratio0.35%0.48%
Risk 5 year sharpe ratio0.971.28
Net assets$2.6B$1.1B
Average market cap$4.7B$36.3B
Average P/E--20.0
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
SRPT Sarepta Therapeutics Inc5.10%
IONS Ionis Pharmaceuticals Inc2.85%
INCY Incyte Corp2.69%
ICPT Intercept Pharmaceuticals Inc2.56%
BLUE bluebird bio Inc2.52%
JUNO Juno Therapeutics Inc2.42%
BIIB Biogen2.39%
REGN Regeneron Pharmaceuticals2.36%
ACAD ACADIA Pharmaceuticals Inc2.32%